<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1996-02-01" modified="2020-10-07" version="182">
<accession>P48552</accession>
<accession>Q8IWE8</accession>
<name>NRIP1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Nuclear receptor-interacting protein 1</fullName>
</recommendedName>
<alternativeName>
<fullName>Nuclear factor RIP140</fullName>
</alternativeName>
<alternativeName>
<fullName>Receptor-interacting protein 140</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">NRIP1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1995" name="EMBO J." volume="14" first="3741" last="3751">
<title>Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor.</title>
<authorList>
<person name="Cavailles V."/>
<person name="Dauvois S."/>
<person name="L'Horset F."/>
<person name="Lopez G."/>
<person name="Hoare S."/>
<person name="Kushner P.J."/>
<person name="Parker M.G."/>
</authorList>
<dbReference type="PubMed" id="7641693"/>
<dbReference type="DOI" id="10.1002/j.1460-2075.1995.tb00044.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ESR1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>VARIANT GLY-448</scope>
<source>
<tissue>Mammary gland</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2000" name="Nature" volume="405" first="311" last="319">
<title>The DNA sequence of human chromosome 21.</title>
<authorList>
<person name="Hattori M."/>
<person name="Fujiyama A."/>
<person name="Taylor T.D."/>
<person name="Watanabe H."/>
<person name="Yada T."/>
<person name="Park H.-S."/>
<person name="Toyoda A."/>
<person name="Ishii K."/>
<person name="Totoki Y."/>
<person name="Choi D.-K."/>
<person name="Groner Y."/>
<person name="Soeda E."/>
<person name="Ohki M."/>
<person name="Takagi T."/>
<person name="Sakaki Y."/>
<person name="Taudien S."/>
<person name="Blechschmidt K."/>
<person name="Polley A."/>
<person name="Menzel U."/>
<person name="Delabar J."/>
<person name="Kumpf K."/>
<person name="Lehmann R."/>
<person name="Patterson D."/>
<person name="Reichwald K."/>
<person name="Rump A."/>
<person name="Schillhabel M."/>
<person name="Schudy A."/>
<person name="Zimmermann W."/>
<person name="Rosenthal A."/>
<person name="Kudoh J."/>
<person name="Shibuya K."/>
<person name="Kawasaki K."/>
<person name="Asakawa S."/>
<person name="Shintani A."/>
<person name="Sasaki T."/>
<person name="Nagamine K."/>
<person name="Mitsuyama S."/>
<person name="Antonarakis S.E."/>
<person name="Minoshima S."/>
<person name="Shimizu N."/>
<person name="Nordsiek G."/>
<person name="Hornischer K."/>
<person name="Brandt P."/>
<person name="Scharfe M."/>
<person name="Schoen O."/>
<person name="Desario A."/>
<person name="Reichelt J."/>
<person name="Kauer G."/>
<person name="Bloecker H."/>
<person name="Ramser J."/>
<person name="Beck A."/>
<person name="Klages S."/>
<person name="Hennig S."/>
<person name="Riesselmann L."/>
<person name="Dagand E."/>
<person name="Wehrmeyer S."/>
<person name="Borzym K."/>
<person name="Gardiner K."/>
<person name="Nizetic D."/>
<person name="Francis F."/>
<person name="Lehrach H."/>
<person name="Reinhardt R."/>
<person name="Yaspo M.-L."/>
</authorList>
<dbReference type="PubMed" id="10830953"/>
<dbReference type="DOI" id="10.1038/35012518"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Skin</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="10948" last="10957">
<title>Regulation of peroxisome proliferator-activated receptor alpha-induced transactivation by the nuclear orphan receptor TAK1/TR4.</title>
<authorList>
<person name="Yan Z.H."/>
<person name="Karam W.G."/>
<person name="Staudinger J.L."/>
<person name="Medvedev A."/>
<person name="Ghanayem B.I."/>
<person name="Jetten A.M."/>
</authorList>
<dbReference type="PubMed" id="9556573"/>
<dbReference type="DOI" id="10.1074/jbc.273.18.10948"/>
</citation>
<scope>INTERACTION WITH NR2C2</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="18121" last="18127">
<title>Receptor interacting protein RIP140 inhibits both positive and negative gene regulation by glucocorticoids.</title>
<authorList>
<person name="Subramaniam N."/>
<person name="Treuter E."/>
<person name="Okret S."/>
</authorList>
<dbReference type="PubMed" id="10364267"/>
<dbReference type="DOI" id="10.1074/jbc.274.25.18121"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH NR3C1</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2001" name="Mol. Cell. Biol." volume="21" first="6181" last="6188">
<title>Acetylation of nuclear hormone receptor-interacting protein RIP140 regulates binding of the transcriptional corepressor CtBP.</title>
<authorList>
<person name="Vo N."/>
<person name="Fjeld C."/>
<person name="Goodman R.H."/>
</authorList>
<dbReference type="PubMed" id="11509661"/>
<dbReference type="DOI" id="10.1128/mcb.21.18.6181-6188.2001"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CTBP1</scope>
<scope>MUTAGENESIS OF 440-PRO--LEU-443 AND LYS-446</scope>
<scope>ACETYLATION AT LYS-446</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2001" name="Mol. Endocrinol." volume="15" first="501" last="511">
<title>Regulation of glucocorticoid receptor activity by 14-3-3-dependent intracellular relocalization of the corepressor RIP140.</title>
<authorList>
<person name="Zilliacus J."/>
<person name="Holter E."/>
<person name="Wakui H."/>
<person name="Tazawa H."/>
<person name="Treuter E."/>
<person name="Gustafsson J.-A."/>
</authorList>
<dbReference type="PubMed" id="11266503"/>
<dbReference type="DOI" id="10.1210/mend.15.4.0624"/>
</citation>
<scope>INTERACTION WITH NR3C1 AND YWHAH</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH NR3C1 AND YWHAH</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2001" name="Mol. Endocrinol." volume="15" first="1586" last="1598">
<title>A new human MR splice variant is a ligand-independent transactivator modulating corticosteroid action.</title>
<authorList>
<person name="Zennaro M.-C."/>
<person name="Souque A."/>
<person name="Viengchareun S."/>
<person name="Poisson E."/>
<person name="Lombes M."/>
</authorList>
<dbReference type="PubMed" id="11518808"/>
<dbReference type="DOI" id="10.1210/mend.15.9.0689"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH NR3C2</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2003" name="Mol. Cell. Biol." volume="23" first="4187" last="4198">
<title>Regulation of subnuclear localization is associated with a mechanism for nuclear receptor corepression by RIP140.</title>
<authorList>
<person name="Tazawa H."/>
<person name="Osman W."/>
<person name="Shoji Y."/>
<person name="Treuter E."/>
<person name="Gustafsson J.-A."/>
<person name="Zilliacus J."/>
</authorList>
<dbReference type="PubMed" id="12773562"/>
<dbReference type="DOI" id="10.1128/mcb.23.12.4187-4198.2003"/>
</citation>
<scope>INTERACTION WITH NR3C1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2003" name="Mol. Endocrinol." volume="17" first="287" last="299">
<title>Receptor-interacting protein 140 binds c-Jun and inhibits estradiol-induced activator protein-1 activity by reversing glucocorticoid receptor-interacting protein 1 effect.</title>
<authorList>
<person name="Teyssier C."/>
<person name="Belguise K."/>
<person name="Galtier F."/>
<person name="Cavailles V."/>
<person name="Chalbos D."/>
</authorList>
<dbReference type="PubMed" id="12554755"/>
<dbReference type="DOI" id="10.1210/me.2002-0324"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ESR1; FOS AND JUN</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="15645" last="15651">
<title>Characterization of four autonomous repression domains in the corepressor receptor interacting protein 140.</title>
<authorList>
<person name="Christian M."/>
<person name="Tullet J.M.A."/>
<person name="Parker M.G."/>
</authorList>
<dbReference type="PubMed" id="14736873"/>
<dbReference type="DOI" id="10.1074/jbc.m313906200"/>
</citation>
<scope>INTERACTION WITH CTBP1 AND CTBP2</scope>
<scope>MUTAGENESIS OF 442-ASP--LEU-443; 567-ASN--LEU-568 AND 948-ASP--LEU-949</scope>
<scope>IDENTIFICATION OF REPRESSION DOMAINS</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2004" name="Nucleic Acids Res." volume="32" first="1957" last="1966">
<title>Multiple domains of the receptor-interacting protein 140 contribute to transcription inhibition.</title>
<authorList>
<person name="Castet A."/>
<person name="Boulahtouf A."/>
<person name="Versini G."/>
<person name="Bonnet S."/>
<person name="Augereau P."/>
<person name="Vignon F."/>
<person name="Khochbin S."/>
<person name="Jalaguier S."/>
<person name="Cavailles V."/>
</authorList>
<dbReference type="PubMed" id="15060175"/>
<dbReference type="DOI" id="10.1093/nar/gkh524"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CTBP1; CTBP2; HDAC1; HDAC2; HDAC5 AND HDAC6</scope>
<scope>MUTAGENESIS OF 442-ASP--LEU-443 AND 567-ASN--LEU-568</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2006" name="Mol. Cell. Proteomics" volume="5" first="2072" last="2082">
<title>Modulation of testicular receptor 4 activity by mitogen-activated protein kinase-mediated phosphorylation.</title>
<authorList>
<person name="Huq M.D."/>
<person name="Gupta P."/>
<person name="Tsai N.P."/>
<person name="Wei L.N."/>
</authorList>
<dbReference type="PubMed" id="16887930"/>
<dbReference type="DOI" id="10.1074/mcp.m600180-mcp200"/>
</citation>
<scope>INTERACTION WITH NR2C2</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2006" name="Nucleic Acids Res." volume="34" first="6126" last="6136">
<title>ZNF366 is an estrogen receptor corepressor that acts through CtBP and histone deacetylases.</title>
<authorList>
<person name="Lopez-Garcia J."/>
<person name="Periyasamy M."/>
<person name="Thomas R.S."/>
<person name="Christian M."/>
<person name="Leao M."/>
<person name="Jat P."/>
<person name="Kindle K.B."/>
<person name="Heery D.M."/>
<person name="Parker M.G."/>
<person name="Buluwela L."/>
<person name="Kamalati T."/>
<person name="Ali S."/>
</authorList>
<dbReference type="PubMed" id="17085477"/>
<dbReference type="DOI" id="10.1093/nar/gkl875"/>
</citation>
<scope>INTERACTION WITH ZNF366</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2011" name="J. Biol. Rhythms" volume="26" first="187" last="199">
<title>Modulation of clock gene expression by the transcriptional coregulator receptor interacting protein 140 (RIP140).</title>
<authorList>
<person name="Poliandri A.H."/>
<person name="Gamsby J.J."/>
<person name="Christian M."/>
<person name="Spinella M.J."/>
<person name="Loros J.J."/>
<person name="Dunlap J.C."/>
<person name="Parker M.G."/>
</authorList>
<dbReference type="PubMed" id="21628546"/>
<dbReference type="DOI" id="10.1177/0748730411401579"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH RORA</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-564 AND SER-807</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-218; SER-671 AND SER-807</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-756 AND LYS-1105</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2017" name="J. Am. Soc. Nephrol." volume="28" first="2364" last="2376">
<title>A dominant mutation in nuclear receptor interacting protein 1 causes urinary tract malformations via dysregulation of retinoic acid signaling.</title>
<authorList>
<person name="Vivante A."/>
<person name="Mann N."/>
<person name="Yonath H."/>
<person name="Weiss A.C."/>
<person name="Getwan M."/>
<person name="Kaminski M.M."/>
<person name="Bohnenpoll T."/>
<person name="Teyssier C."/>
<person name="Chen J."/>
<person name="Shril S."/>
<person name="van der Ven A.T."/>
<person name="Ityel H."/>
<person name="Schmidt J.M."/>
<person name="Widmeier E."/>
<person name="Bauer S.B."/>
<person name="Sanna-Cherchi S."/>
<person name="Gharavi A.G."/>
<person name="Lu W."/>
<person name="Magen D."/>
<person name="Shukrun R."/>
<person name="Lifton R.P."/>
<person name="Tasic V."/>
<person name="Stanescu H.C."/>
<person name="Cavailles V."/>
<person name="Kleta R."/>
<person name="Anikster Y."/>
<person name="Dekel B."/>
<person name="Kispert A."/>
<person name="Lienkamp S.S."/>
<person name="Hildebrandt F."/>
</authorList>
<dbReference type="PubMed" id="28381549"/>
<dbReference type="DOI" id="10.1681/asn.2016060694"/>
</citation>
<scope>FUNCTION</scope>
<scope>INVOLVEMENT IN CAKUT3</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-111; LYS-170; LYS-195; LYS-198; LYS-372; LYS-508; LYS-756; LYS-802; LYS-850; LYS-901; LYS-931; LYS-1105; LYS-1115 AND LYS-1154</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2018" name="J. Am. Soc. Nephrol." volume="29" first="2348" last="2361">
<title>Whole-exome sequencing identifies causative mutations in families with congenital anomalies of the kidney and urinary tract.</title>
<authorList>
<person name="van der Ven A.T."/>
<person name="Connaughton D.M."/>
<person name="Ityel H."/>
<person name="Mann N."/>
<person name="Nakayama M."/>
<person name="Chen J."/>
<person name="Vivante A."/>
<person name="Hwang D.Y."/>
<person name="Schulz J."/>
<person name="Braun D.A."/>
<person name="Schmidt J.M."/>
<person name="Schapiro D."/>
<person name="Schneider R."/>
<person name="Warejko J.K."/>
<person name="Daga A."/>
<person name="Majmundar A.J."/>
<person name="Tan W."/>
<person name="Jobst-Schwan T."/>
<person name="Hermle T."/>
<person name="Widmeier E."/>
<person name="Ashraf S."/>
<person name="Amar A."/>
<person name="Hoogstraaten C.A."/>
<person name="Hugo H."/>
<person name="Kitzler T.M."/>
<person name="Kause F."/>
<person name="Kolvenbach C.M."/>
<person name="Dai R."/>
<person name="Spaneas L."/>
<person name="Amann K."/>
<person name="Stein D.R."/>
<person name="Baum M.A."/>
<person name="Somers M.J.G."/>
<person name="Rodig N.M."/>
<person name="Ferguson M.A."/>
<person name="Traum A.Z."/>
<person name="Daouk G.H."/>
<person name="Bogdanovic R."/>
<person name="Stajic N."/>
<person name="Soliman N.A."/>
<person name="Kari J.A."/>
<person name="El Desoky S."/>
<person name="Fathy H.M."/>
<person name="Milosevic D."/>
<person name="Al-Saffar M."/>
<person name="Awad H.S."/>
<person name="Eid L.A."/>
<person name="Selvin A."/>
<person name="Senguttuvan P."/>
<person name="Sanna-Cherchi S."/>
<person name="Rehm H.L."/>
<person name="MacArthur D.G."/>
<person name="Lek M."/>
<person name="Laricchia K.M."/>
<person name="Wilson M.W."/>
<person name="Mane S.M."/>
<person name="Lifton R.P."/>
<person name="Lee R.S."/>
<person name="Bauer S.B."/>
<person name="Lu W."/>
<person name="Reutter H.M."/>
<person name="Tasic V."/>
<person name="Shril S."/>
<person name="Hildebrandt F."/>
</authorList>
<dbReference type="PubMed" id="30143558"/>
<dbReference type="DOI" id="10.1681/asn.2017121265"/>
</citation>
<scope>INVOLVEMENT IN CAKUT3</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="37773" last="37781">
<title>X-ray crystal structures of the estrogen-related receptor-gamma ligand binding domain in three functional states reveal the molecular basis of small molecule regulation.</title>
<authorList>
<person name="Wang L."/>
<person name="Zuercher W.J."/>
<person name="Consler T.G."/>
<person name="Lambert M.H."/>
<person name="Miller A.B."/>
<person name="Orband-Miller L.A."/>
<person name="McKee D.D."/>
<person name="Willson T.M."/>
<person name="Nolte R.T."/>
</authorList>
<dbReference type="PubMed" id="16990259"/>
<dbReference type="DOI" id="10.1074/jbc.m608410200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 366-390 IN COMPLEX WITH ESRRG</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2005" name="J. Exp. Clin. Assist. Reprod." volume="2" first="11" last="11">
<title>Preliminary molecular genetic analysis of the receptor interacting protein 140 (RIP140) in women affected by endometriosis.</title>
<authorList>
<person name="Caballero V."/>
<person name="Ruiz R."/>
<person name="Sainz J.A."/>
<person name="Cruz M."/>
<person name="Lopez-Nevot M.A."/>
<person name="Galan J.J."/>
<person name="Real L.M."/>
<person name="de Castro F."/>
<person name="Lopez-Villaverde V."/>
<person name="Ruiz A."/>
</authorList>
<dbReference type="PubMed" id="16131398"/>
<dbReference type="DOI" id="10.1186/1743-1050-2-11"/>
</citation>
<scope>VARIANTS ARG-221; VAL-441; GLY-448; LEU-803 AND PHE-1079</scope>
</reference>
<comment type="function">
<text evidence="8 10 12 13 14 17 22 23 25">Modulates transcriptional activation by steroid receptors such as NR3C1, NR3C2 and ESR1. Also modulates transcriptional repression by nuclear hormone receptors. Positive regulator of the circadian clock gene expression: stimulates transcription of ARNTL/BMAL1, CLOCK and CRY1 by acting as a coactivator for RORA and RORC. Involved in the regulation of ovarian function (By similarity). Plays a role in renal development (PubMed:28381549).</text>
</comment>
<comment type="subunit">
<text evidence="8 10 11 12 13 14 15 16 17 19 20 21 22 25 26">Interacts with RARA and RXRB homodimers and RARA/RXRB heterodimers in the presence of ligand. Interacts with HDAC1 and HDAC3 via its N-terminal domain. Interacts with NR2C1 (sumoylated form and via the ligand-binding domain); the interaction results in promoting the repressor activity of NR2C1 (By similarity). Interacts with CTBP1, CTBP2, ESR1, HDAC1, HDAC2, HDAC5, HDAC6, NR2C2, NR3C1, NR3C2, YWHAH, JUN and FOS. Found in a complex with both NR3C1 and YWHAH. Interacts with ZNF366. Interacts with RORA.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-746484">
<id>P48552</id>
</interactant>
<interactant intactId="EBI-351829">
<id>O15145</id>
<label>ARPC3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-746484">
<id>P48552</id>
</interactant>
<interactant intactId="EBI-11519926">
<id>Q6PI77</id>
<label>BHLHB9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-746484">
<id>P48552</id>
</interactant>
<interactant intactId="EBI-739624">
<id>Q8NHQ1</id>
<label>CEP70</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-746484">
<id>P48552</id>
</interactant>
<interactant intactId="EBI-908846">
<id>Q13363</id>
<label>CTBP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-746484">
<id>P48552</id>
</interactant>
<interactant intactId="EBI-719459">
<id>P26358</id>
<label>DNMT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-746484">
<id>P48552</id>
</interactant>
<interactant intactId="EBI-12001340">
<id>P62508-3</id>
<label>ESRRG</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-746484">
<id>P48552</id>
</interactant>
<interactant intactId="EBI-912547">
<id>Q13642</id>
<label>FHL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-746484">
<id>P48552</id>
</interactant>
<interactant intactId="EBI-618309">
<id>Q08379</id>
<label>GOLGA2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-746484">
<id>P48552</id>
</interactant>
<interactant intactId="EBI-607682">
<id>O15379</id>
<label>HDAC3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-746484">
<id>P48552</id>
</interactant>
<interactant intactId="EBI-740738">
<id>O95751</id>
<label>LDOC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-746484">
<id>P48552</id>
</interactant>
<interactant intactId="EBI-2692890">
<id>Q96KN3</id>
<label>PKNOX2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-746484">
<id>P48552</id>
</interactant>
<interactant intactId="EBI-78738">
<id>Q99873</id>
<label>PRMT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-746484">
<id>P48552</id>
</interactant>
<interactant intactId="EBI-413374">
<id>P10276</id>
<label>RARA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-746484">
<id>P48552</id>
</interactant>
<interactant intactId="EBI-10197061">
<id>P10276-2</id>
<label>RARA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-746484">
<id>P48552</id>
</interactant>
<interactant intactId="EBI-2813661">
<id>Q8N895</id>
<label>ZNF366</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="11 15 17 25">Nucleus</location>
</subcellularLocation>
<text>Localized to discrete foci and redistributes to larger nuclear domains upon binding to ligand-bound NR3C1.</text>
</comment>
<comment type="induction">
<text evidence="22">Expressed in a circadian manner in the liver (at protein level).</text>
</comment>
<comment type="domain">
<text evidence="7">Contains 9 Leu-Xaa-Xaa-Leu-Leu (LXXLL) motifs, which have different affinities for nuclear receptors. The C-terminal LTKTNPILYYMLQK motif is required for ligand-dependent interaction with RAAR and RXRB homodimers and heterodimers, for the corepressor activity, and for the formation of an HDAC3 complex with RARA/RXRB (By similarity). Contains at least four autonomous repression domains (RD1-4). RD1 functions via a histone deacetylase (HDAC)-independent mechanism, whereas RD2, RD3 and RD4 can function by HDAC-dependent or independent mechanisms, depending on cell type. RD2 is dependent on CTBP binding.</text>
</comment>
<comment type="PTM">
<text evidence="7 12">Acetylation regulates its nuclear translocation and corepressive activity (By similarity). Acetylation abolishes interaction with CTBP1. Phosphorylation enhances interaction with YWHAH.</text>
</comment>
<comment type="disease" evidence="23 24">
<disease id="DI-05447">
<name>Congenital anomalies of kidney and urinary tract 3</name>
<acronym>CAKUT3</acronym>
<description>A disorder encompassing a broad spectrum of renal and urinary tract malformations that include renal agenesis, kidney hypodysplasia, multicystic kidney dysplasia, duplex collecting system, posterior urethral valves and ureter abnormalities. Congenital anomalies of kidney and urinary tract are the commonest cause of chronic kidney disease in children. CAKUT3 inheritance is autosomal dominant.</description>
<dbReference type="MIM" id="618270"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/NRIP1ID44067ch21q11.html"/>
</comment>
<dbReference type="EMBL" id="X84373">
<property type="protein sequence ID" value="CAA59108.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF248484">
<property type="protein sequence ID" value="AAF62185.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF127577">
<property type="protein sequence ID" value="AAF35255.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL163207">
<property type="protein sequence ID" value="CAB90396.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC040361">
<property type="protein sequence ID" value="AAH40361.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS13568.1"/>
<dbReference type="PIR" id="S57348">
<property type="entry name" value="S57348"/>
</dbReference>
<dbReference type="RefSeq" id="NP_003480.2">
<property type="nucleotide sequence ID" value="NM_003489.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005261120.1">
<property type="nucleotide sequence ID" value="XM_005261063.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005261122.1">
<property type="nucleotide sequence ID" value="XM_005261065.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011528049.1">
<property type="nucleotide sequence ID" value="XM_011529747.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011528050.1">
<property type="nucleotide sequence ID" value="XM_011529748.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011528051.1">
<property type="nucleotide sequence ID" value="XM_011529749.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011528053.1">
<property type="nucleotide sequence ID" value="XM_011529751.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011528054.1">
<property type="nucleotide sequence ID" value="XM_011529752.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016883962.1">
<property type="nucleotide sequence ID" value="XM_017028473.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016883963.1">
<property type="nucleotide sequence ID" value="XM_017028474.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016883964.1">
<property type="nucleotide sequence ID" value="XM_017028475.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016883965.1">
<property type="nucleotide sequence ID" value="XM_017028476.1"/>
</dbReference>
<dbReference type="PDB" id="2GPO">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="C=366-390"/>
</dbReference>
<dbReference type="PDB" id="2GPP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="C/D=366-390"/>
</dbReference>
<dbReference type="PDB" id="4S14">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.54"/>
<property type="chains" value="C=499-510"/>
</dbReference>
<dbReference type="PDB" id="4S15">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="C/D=499-510"/>
</dbReference>
<dbReference type="PDB" id="5NTI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="P/Q/R/S=493-512"/>
</dbReference>
<dbReference type="PDB" id="5NTN">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="P/Q/R/S=493-512"/>
</dbReference>
<dbReference type="PDB" id="5NTW">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.64"/>
<property type="chains" value="P/Q/R/S=493-512"/>
</dbReference>
<dbReference type="PDB" id="5NU1">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="P/Q=493-512"/>
</dbReference>
<dbReference type="PDB" id="6FZU">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="P/Q=493-512"/>
</dbReference>
<dbReference type="PDB" id="6G05">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="P/Q=493-512"/>
</dbReference>
<dbReference type="PDB" id="6G07">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.66"/>
<property type="chains" value="P/Q/R/S=493-512"/>
</dbReference>
<dbReference type="PDBsum" id="2GPO"/>
<dbReference type="PDBsum" id="2GPP"/>
<dbReference type="PDBsum" id="4S14"/>
<dbReference type="PDBsum" id="4S15"/>
<dbReference type="PDBsum" id="5NTI"/>
<dbReference type="PDBsum" id="5NTN"/>
<dbReference type="PDBsum" id="5NTW"/>
<dbReference type="PDBsum" id="5NU1"/>
<dbReference type="PDBsum" id="6FZU"/>
<dbReference type="PDBsum" id="6G05"/>
<dbReference type="PDBsum" id="6G07"/>
<dbReference type="SMR" id="P48552"/>
<dbReference type="BioGRID" id="113843">
<property type="interactions" value="64"/>
</dbReference>
<dbReference type="DIP" id="DIP-5964N"/>
<dbReference type="IntAct" id="P48552">
<property type="interactions" value="28"/>
</dbReference>
<dbReference type="MINT" id="P48552"/>
<dbReference type="STRING" id="9606.ENSP00000383063"/>
<dbReference type="DrugBank" id="DB06884">
<property type="generic name" value="4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE"/>
</dbReference>
<dbReference type="iPTMnet" id="P48552"/>
<dbReference type="PhosphoSitePlus" id="P48552"/>
<dbReference type="BioMuta" id="NRIP1"/>
<dbReference type="DMDM" id="9988061"/>
<dbReference type="EPD" id="P48552"/>
<dbReference type="jPOST" id="P48552"/>
<dbReference type="MassIVE" id="P48552"/>
<dbReference type="MaxQB" id="P48552"/>
<dbReference type="PaxDb" id="P48552"/>
<dbReference type="PeptideAtlas" id="P48552"/>
<dbReference type="PRIDE" id="P48552"/>
<dbReference type="ProteomicsDB" id="55908"/>
<dbReference type="Antibodypedia" id="5789">
<property type="antibodies" value="224 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="8204"/>
<dbReference type="Ensembl" id="ENST00000318948">
<property type="protein sequence ID" value="ENSP00000327213"/>
<property type="gene ID" value="ENSG00000180530"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000400199">
<property type="protein sequence ID" value="ENSP00000383060"/>
<property type="gene ID" value="ENSG00000180530"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000400202">
<property type="protein sequence ID" value="ENSP00000383063"/>
<property type="gene ID" value="ENSG00000180530"/>
</dbReference>
<dbReference type="GeneID" id="8204"/>
<dbReference type="KEGG" id="hsa:8204"/>
<dbReference type="UCSC" id="uc002yjx.2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="8204"/>
<dbReference type="DisGeNET" id="8204"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000180530.9"/>
<dbReference type="GeneCards" id="NRIP1"/>
<dbReference type="HGNC" id="HGNC:8001">
<property type="gene designation" value="NRIP1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000180530">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="NRIP1"/>
<dbReference type="MIM" id="602490">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="618270">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P48552"/>
<dbReference type="OpenTargets" id="ENSG00000180530"/>
<dbReference type="PharmGKB" id="PA31780"/>
<dbReference type="eggNOG" id="ENOG502QS1C">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000007999"/>
<dbReference type="HOGENOM" id="CLU_008553_0_0_1"/>
<dbReference type="InParanoid" id="P48552"/>
<dbReference type="KO" id="K17965"/>
<dbReference type="OMA" id="GPETHKD"/>
<dbReference type="OrthoDB" id="345693at2759"/>
<dbReference type="PhylomeDB" id="P48552"/>
<dbReference type="TreeFam" id="TF332210"/>
<dbReference type="PathwayCommons" id="P48552"/>
<dbReference type="Reactome" id="R-HSA-3899300">
<property type="pathway name" value="SUMOylation of transcription cofactors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-400253">
<property type="pathway name" value="Circadian Clock"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9018519">
<property type="pathway name" value="Estrogen-dependent gene expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9029558">
<property type="pathway name" value="NR1H2 &amp; NR1H3 regulate gene expression linked to lipogenesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9632974">
<property type="pathway name" value="NR1H2 &amp; NR1H3 regulate gene expression linked to gluconeogenesis"/>
</dbReference>
<dbReference type="SignaLink" id="P48552"/>
<dbReference type="SIGNOR" id="P48552"/>
<dbReference type="BioGRID-ORCS" id="8204">
<property type="hits" value="2 hits in 876 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="NRIP1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P48552"/>
<dbReference type="GeneWiki" id="NRIP1"/>
<dbReference type="GenomeRNAi" id="8204"/>
<dbReference type="Pharos" id="P48552">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:P48552"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 21"/>
</dbReference>
<dbReference type="RNAct" id="P48552">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000180530">
<property type="expression patterns" value="Expressed in uterine cervix and 253 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P48552">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P48552">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0001650">
<property type="term" value="C:fibrillar center"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0000118">
<property type="term" value="C:histone deacetylase complex"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016607">
<property type="term" value="C:nuclear speck"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005730">
<property type="term" value="C:nucleolus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030331">
<property type="term" value="F:estrogen receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035259">
<property type="term" value="F:glucocorticoid receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042826">
<property type="term" value="F:histone deacetylase binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035257">
<property type="term" value="F:nuclear hormone receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046965">
<property type="term" value="F:retinoid X receptor binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003713">
<property type="term" value="F:transcription coactivator activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003714">
<property type="term" value="F:transcription corepressor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071392">
<property type="term" value="P:cellular response to estradiol stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032922">
<property type="term" value="P:circadian regulation of gene expression"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007623">
<property type="term" value="P:circadian rhythm"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019915">
<property type="term" value="P:lipid storage"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001543">
<property type="term" value="P:ovarian follicle rupture"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="IDEAL" id="IID00050"/>
<dbReference type="InterPro" id="IPR026649">
<property type="entry name" value="NRIP1"/>
</dbReference>
<dbReference type="InterPro" id="IPR031405">
<property type="entry name" value="NRIP1_RD1"/>
</dbReference>
<dbReference type="InterPro" id="IPR031406">
<property type="entry name" value="NRIP1_RD2"/>
</dbReference>
<dbReference type="InterPro" id="IPR031407">
<property type="entry name" value="NRIP1_RD3"/>
</dbReference>
<dbReference type="InterPro" id="IPR031408">
<property type="entry name" value="NRIP1_RD4"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR15088">
<property type="entry name" value="PTHR15088"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF15687">
<property type="entry name" value="NRIP1_repr_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF15688">
<property type="entry name" value="NRIP1_repr_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF15689">
<property type="entry name" value="NRIP1_repr_3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF15690">
<property type="entry name" value="NRIP1_repr_4"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0090">Biological rhythms</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Nuclear receptor-interacting protein 1" id="PRO_0000057951">
<location>
<begin position="1"/>
<end position="1158"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with ZNF366" evidence="21">
<location>
<begin position="1"/>
<end position="415"/>
</location>
</feature>
<feature type="region of interest" description="Repression domain 1">
<location>
<begin position="78"/>
<end position="333"/>
</location>
</feature>
<feature type="region of interest" description="Repression domain 2">
<location>
<begin position="410"/>
<end position="700"/>
</location>
</feature>
<feature type="region of interest" description="Required for targeting to small nuclear foci">
<location>
<begin position="431"/>
<end position="472"/>
</location>
</feature>
<feature type="region of interest" description="Repression domain 3">
<location>
<begin position="735"/>
<end position="885"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with ZNF366" evidence="21">
<location>
<begin position="753"/>
<end position="1158"/>
</location>
</feature>
<feature type="region of interest" description="Repression domain 4">
<location>
<begin position="1118"/>
<end position="1158"/>
</location>
</feature>
<feature type="short sequence motif" description="LXXLL motif 1">
<location>
<begin position="21"/>
<end position="25"/>
</location>
</feature>
<feature type="short sequence motif" description="LXXLL motif 2">
<location>
<begin position="133"/>
<end position="137"/>
</location>
</feature>
<feature type="short sequence motif" description="LXXLL motif 3">
<location>
<begin position="185"/>
<end position="189"/>
</location>
</feature>
<feature type="short sequence motif" description="LXXLL motif 4">
<location>
<begin position="266"/>
<end position="270"/>
</location>
</feature>
<feature type="short sequence motif" description="LXXLL motif 5">
<location>
<begin position="380"/>
<end position="384"/>
</location>
</feature>
<feature type="short sequence motif" description="CTBP-binding; principal site">
<location>
<begin position="440"/>
<end position="446"/>
</location>
</feature>
<feature type="short sequence motif" description="LXXLL motif 6">
<location>
<begin position="500"/>
<end position="504"/>
</location>
</feature>
<feature type="short sequence motif" description="CTBP-binding">
<location>
<begin position="565"/>
<end position="569"/>
</location>
</feature>
<feature type="short sequence motif" description="CTBP-binding" evidence="9">
<location>
<begin position="599"/>
<end position="603"/>
</location>
</feature>
<feature type="short sequence motif" description="LXXLL motif 7">
<location>
<begin position="713"/>
<end position="717"/>
</location>
</feature>
<feature type="short sequence motif" description="LXXLL motif 8">
<location>
<begin position="819"/>
<end position="823"/>
</location>
</feature>
<feature type="short sequence motif" description="LXXLL motif 9">
<location>
<begin position="936"/>
<end position="940"/>
</location>
</feature>
<feature type="short sequence motif" description="CTBP-binding">
<location>
<begin position="946"/>
<end position="950"/>
</location>
</feature>
<feature type="short sequence motif" description="Ligand-dependent nuclear receptor binding" evidence="7">
<location>
<begin position="1061"/>
<end position="1074"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="104"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="8">
<location>
<position position="111"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="8">
<location>
<position position="158"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="8">
<location>
<position position="207"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="218"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="8">
<location>
<position position="286"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="8">
<location>
<position position="310"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="356"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="378"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="12">
<location>
<position position="446"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="8">
<location>
<position position="481"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="487"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="518"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="8">
<location>
<position position="528"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="542"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="564"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="8">
<location>
<position position="606"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="671"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 4">
<location>
<position position="807"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="8">
<location>
<position position="931"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="1001"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="6">
<location>
<position position="111"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="6">
<location>
<position position="170"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="6">
<location>
<position position="195"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="6">
<location>
<position position="198"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="6">
<location>
<position position="372"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="6">
<location>
<position position="508"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="5 6">
<location>
<position position="756"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="6">
<location>
<position position="802"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="6">
<location>
<position position="850"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="6">
<location>
<position position="901"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="6">
<location>
<position position="931"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="5 6">
<location>
<position position="1105"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="6">
<location>
<position position="1115"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="6">
<location>
<position position="1154"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs9941840." id="VAR_051241">
<original>V</original>
<variation>I</variation>
<location>
<position position="37"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs139263261." id="VAR_023706" evidence="18">
<original>H</original>
<variation>R</variation>
<location>
<position position="221"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2228507." id="VAR_034142">
<original>Y</original>
<variation>F</variation>
<location>
<position position="315"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs150468995." id="VAR_023707" evidence="18">
<original>I</original>
<variation>V</variation>
<location>
<position position="441"/>
</location>
</feature>
<feature type="sequence variant" description="Common polymorphism; dbSNP:rs2229742." id="VAR_023708" evidence="18 25">
<original>R</original>
<variation>G</variation>
<location>
<position position="448"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs9975169." id="VAR_051242">
<original>N</original>
<variation>S</variation>
<location>
<position position="567"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs61750208." id="VAR_023709" evidence="18">
<original>S</original>
<variation>L</variation>
<location>
<position position="803"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs140803495." id="VAR_023710" evidence="18">
<original>V</original>
<variation>F</variation>
<location>
<position position="1079"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with CTBP1." evidence="12">
<original>PIDL</original>
<variation>AAAA</variation>
<location>
<begin position="440"/>
<end position="443"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with CTBP1 and attenuates nuclear hormone receptor-dependent transcription repression.">
<original>PID</original>
<variation>AIA</variation>
<location>
<begin position="440"/>
<end position="442"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces, but does not completely abolish, interaction with CTBP. Reduces transcriptional repression." evidence="16 17">
<original>DL</original>
<variation>AA</variation>
<location>
<begin position="442"/>
<end position="443"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts interaction with CTBP1, and CTBP2 to a lesser extent. Disrupts transcriptional repression; when associated with 567-AS-568." evidence="16 17">
<original>DL</original>
<variation>AS</variation>
<location>
<begin position="442"/>
<end position="443"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts interaction with CTBP1. Decreases lysine acetylation. Disrupts nuclear hormone receptor-dependent transcription repression." evidence="12">
<original>K</original>
<variation>Q</variation>
<location>
<position position="446"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not disrupt nuclear hormone receptor-dependent transcription repression." evidence="12">
<original>K</original>
<variation>R</variation>
<location>
<position position="446"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts transcriptional repression." evidence="16 17">
<original>NL</original>
<variation>AA</variation>
<location>
<begin position="567"/>
<end position="568"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts interaction with CTBP1 and CTBP2. Disrupts transcriptional repression; when associated with 442-AS-443." evidence="16 17">
<original>NL</original>
<variation>AS</variation>
<location>
<begin position="567"/>
<end position="568"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not further disrupt transcriptional repression; when associated with 442-AA-443 and 567-AA-568.">
<original>SMDLT</original>
<variation>PIAAS</variation>
<location>
<begin position="599"/>
<end position="603"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes CTBP binding but retains transcriptional repressor activity." evidence="16">
<original>DL</original>
<variation>AA</variation>
<location>
<begin position="948"/>
<end position="949"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA59108." ref="1" evidence="27">
<original>P</original>
<variation>R</variation>
<location>
<position position="124"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA59108." ref="1" evidence="27">
<original>NKGKSE</original>
<variation>TKGRVK</variation>
<location>
<begin position="721"/>
<end position="726"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; AAH40361." ref="3" evidence="27">
<original>S</original>
<variation>I</variation>
<location>
<position position="954"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA59108." ref="1" evidence="27">
<original>T</original>
<variation>A</variation>
<location>
<position position="1080"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="379"/>
<end position="385"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="500"/>
<end position="505"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2GPO"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5NTW"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000250"/>
<evidence key="8" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q8CBD1"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000255"/>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10364267"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11266503"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11509661"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11518808"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12554755"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12773562"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14736873"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15060175"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16131398"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16887930"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16990259"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17085477"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21628546"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28381549"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="30143558"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7641693"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9556573"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000305"/>
<sequence length="1158" mass="126942" checksum="81FC424968E9A5F6" modified="2000-12-01" version="2">MTHGEELGSDVHQDSIVLTYLEGLLMHQAAGGSGTAVDKKSAGHNEEDQNFNISGSAFPTCQSNGPVLNTHTYQGSGMLHLKKARLLQSSEDWNAAKRKRLSDSIMNLNVKKEALLAGMVDSVPKGKQDSTLLASLLQSFSSRLQTVALSQQIRQSLKEQGYALSHDSLKVEKDLRCYGVASSHLKTLLKKSKVKDQKPDTNLPDVTKNLIRDRFAESPHHVGQSGTKVMSEPLSCAARLQAVASMVEKRASPATSPKPSVACSQLALLLSSEAHLQQYSREHALKTQNANQAASERLAAMARLQENGQKDVGSYQLPKGMSSHLNGQARTSSSKLMASKSSATVFQNPMGIIPSSPKNAGYKNSLERNNIKQAANNSLLLHLLKSQTIPKPMNGHSHSERGSIFEESSTPTTIDEYSDNNPSFTDDSSGDESSYSNCVPIDLSCKHRTEKSESDQPVSLDNFTQSLLNTWDPKVPDVDIKEDQDTSKNSKLNSHQKVTLLQLLLGHKNEENVEKNTSPQGVHNDVSKFNTQNYARTSVIESPSTNRTTPVSTPPLLTSSKAGSPINLSQHSLVIKWNSPPYVCSTQSEKLTNTASNHSMDLTKSKDPPGEKPAQNEGAQNSATFSASKLLQNLAQCGMQSSMSVEEQRPSKQLLTGNTDKPIGMIDRLNSPLLSNKTNAVEENKAFSSQPTGPEPGLSGSEIENLLERRTVLQLLLGNPNKGKSEKKEKTPLRDESTQEHSERALSEQILMVKIKSEPCDDLQIPNTNVHLSHDAKSAPFLGMAPAVQRSAPALPVSEDFKSEPVSPQDFSFSKNGLLSRLLRQNQDSYLADDSDRSHRNNEMALLESKNLCMVPKKRKLYTEPLENPFKKMKNNIVDAANNHSAPEVLYGSLLNQEELKFSRNDLEFKYPAGHGSASESEHRSWARESKSFNVLKQLLLSENCVRDLSPHRSNSVADSKKKGHKNNVTNSKPEFSISSLNGLMYSSTQPSSCMDNRTFSYPGVVKTPVSPTFPEHLGCAGSRPESGLLNGCSMPSEKGPIKWVITDAEKNEYEKDSPRLTKTNPILYYMLQKGGNSVTSRETQDKDIWREASSAESVSQVTAKEELLPTAETKASFFNLRSPYNSHMGNNASRPHSANGEVYGLLGSVLTIKKESE</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

